Testing effectiveness (Phase 2)Ended earlyNCT00751296
What this trial is testing
Study of Lenalidomide in Previously Untreated, Symptomatic Chronic Lymphocytic Leukemia (CLL)
Who this might be right for
Chronic Lymphocytic Leukaemia
University Health Network, Toronto 27